{
  "nctId": "NCT05791604",
  "briefTitle": "The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics",
  "officialTitle": "The Safety and Effectiveness Study of Prebiotics and Probiotics in the Intervention of Obesity in Children With Prader-Willi Syndrome",
  "protocolDocument": {
    "nctId": "NCT05791604",
    "filename": "Prot_SAP_ICF_000.pdf",
    "label": "Study Protocol, Statistical Analysis Plan, and Informed Consent Form",
    "date": "2023-01-05",
    "uploadDate": "2023-03-17T01:01",
    "size": 362692,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05791604/document/Prot_SAP_ICF_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": true
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 60,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2023-04-01",
    "completionDate": "2026-07-31",
    "primaryCompletionDate": "2026-03-31",
    "firstSubmitDate": "2023-03-06",
    "firstPostDate": "2023-03-30"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Pre-adolescent children with Prader Willi syndrome which were definitely diagnosed by gene testing.\n* Consistent with the diagnostic criteria for obesity.\n* Not participate in other research projects at present or three months before the research;\n* Agree to participate in the test and obtain the consent of their parents; voluntarily be the subjects and sign the informed consent form.\n\nExclusion Criteria:\n\n* Losing weight in ways other than the intervention measures of this project, such as taking weight loss drugs or known drugs that cause weight change;\n* Use antibiotics within 1 month before the study and lasted for 3 days or more;\n* Use probiotics within 1 month before the study and lasted for 3 days or more;\n* Complicated with liver and renal insufficiency (alanine aminotransferase and serum creatinine indexes exceed 2 times the upper limit of the normal value set by the hospital);\n* Have gastrointestinal diseases affecting food digestion and absorption (such as severe diarrhea, constipation, severe gastrointestinal inflammation, active gastrointestinal ulcer, acute cholecystitis, etc.); severe diarrhea refers to watery stool 3 or more times a day and lasts for 3 or more days. severe constipation refers to defecation 2 or less times a week with difficulty in defecation;\n* Surgery was performed within 1 year before the study (except for appendicitis and hernia surgery);\n* Have hepatitis B, active tuberculosis, AIDS and other infectious diseases;\n* Those who are suffering from mental illness and are taking psychotropic drugs such as antidepressants.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "3 Years",
    "maximumAge": "10 Years",
    "stdAges": [
      "CHILD"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Body mass index",
        "description": "Body mass index is calculated as weight (kg)/\\[Height (m)\\^2\\]. Weight and height will be combined to report BMI in kg/m\\^2.",
        "timeFrame": "12 weeks"
      }
    ],
    "secondary": [
      {
        "measure": "Body composition",
        "description": "Body composition including body fat percentage will be measured through body composition meter.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "The structure of gut microbiota",
        "description": "The 16s rRNA genes of fecal samples were analyzed.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Height",
        "description": "The height is accurate to 0.1cm.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Weight",
        "description": "The weight is accurate to 0.1kg.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Waist circumference",
        "description": "The waist circumference is accurate to 0.1cm.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Glycosylated hemoglobin level",
        "description": "The glycosylated hemoglobin is accurate to 0.1%.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Fast triglyceride level",
        "description": "The fast triglyceride level will be measured by IMMULITE 1000 (Siemens,Germany).",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Fast total cholesterol level",
        "description": "The fast total cholesterol level will be measured by IMMULITE 1000 (Siemens,Germany).",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Fast low density lipoprotein level",
        "description": "The fast low density lipoprotein level will be measured by IMMULITE 1000 (Siemens,Germany).",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Fast high density lipoprotein level",
        "description": "The fast high density lipoprotein level will be measured by IMMULITE 1000 (Siemens,Germany).",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Defecation status",
        "description": "Care givers describe the defecation status in the past 1 week, including the frequency, nature, and color.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Abdominal pain",
        "description": "Care givers describe whether abdominal pain occurs, and if so, provide frequency.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Excessive flatulence",
        "description": "Care givers describe whether excessive flatulence occurs, and if so, provide frequency.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Fast insulin level",
        "description": "The fast insulin level will be measured by IMMULITE 1000 (Siemens,Germany).",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Fast glucose level",
        "description": "The fast glucose level is detected by fingertip blood with blood glucose meter.",
        "timeFrame": "4 weeks and 12 weeks"
      },
      {
        "measure": "Body mass index",
        "description": "Body mass index is calculated as weight (kg)/\\[Height (m)\\^2\\]. Weight and height will be combined to report BMI in kg/m\\^2.",
        "timeFrame": "4 weeks"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 16,
      "otherCount": 0,
      "totalCount": 17
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:30:16.371Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}